Sort by
Refine Your Search
-
, and an ability to link fundamental science to real-world applications. The ideal candidate will also have: a PhD degree in nanotechnology, biotechnology, immunology, chemistry, biomedical/chemical
-
nitrogenase catalyzed ammonia synthesis in the triple-phase reactor. Your profile Completed PhD in the field of Biotechnology, Biochemistry, Biochemical Engineering, Molecular Biology, or a relevant, Strong
-
Chemistry / GEOMAR Centre for Marine Biotechnology is seeking an experienced Post-doctoral researcher (m/f/d) in ‘‘Marine Microbial Natural Product Chemistry’’. The position is available for 3 years starting
-
, co-cultivation and the synthetic microbial community (SynCom) will be employed. GEOMAR Research Unit Marine Natural Products Chemistry / GEOMAR Centre for Marine Biotechnology is seeking an experienced
-
such as biochemistry, molecular biology, structural biology, or biotechnology. Documented experience in laboratory work. The applicant should have extensive laboratory experience and be able to conduct
-
applications in fundamental research, biotechnology and synthetic biology. Our multidisciplinary research combines high-throughput genome editing, state-of-the-art genomics methods, and computational biology
-
data using MEFISTO. Nature Methods (2022) Kleshchevnikov, Vitalii, et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nature Biotechnology (2022) Argelaguet, R., et al. Multi
-
is situated at the forefront of industrial biotechnology, metabolic engineering and synthetic biology. They focus on the development of standardized, automatable, and generic tools and technologies and
-
areas: biology, developmental biology, neuroscience, cancer biology, genetics, biotechnology, physiology, anatomy, cell biology, molecular biology, genetics or similar. Experience in some of the following
-
researcher (m/f/d) (biology, biochemistry, biotechnology or related areas) Our project investigates the mechanisms of inherited bone marrow failure and its progression into hematological malignancies. Our